Tuaimenal A, a meroterpene from the Irish deep-sea soft coral Drifa sp., displays antiviral and antiproliferative bioactivity.

17 January 2022, Version 2

Abstract

Cold water benthic environments are a prolific source of structurally diverse molecules with a range of bioactivity against human disease. Specimens of a previously chemically unexplored soft coral, Drifa sp., were collected during a deep-sea cruise that sampled marine invertebrates along the Irish continental margin in 2018. Tuaimenal A (1), a cyclized merosesquiterpenoid representing a new carbon scaffold with a highly substituted chromene core, was discovered through exploration of the soft coral secondary metabolome via NMR-guided fractionation. Absolute stereochemistry was determined through vibrational circular dichroism. Functional assays and in silico docking experiments found tuaimenal A active against two major health burdens: SARS-CoV-2 and cancer. Biochemical and cell-based assays established that tuaimenal A effectively and selectively inhibits the viral main protease (3CLpro) and mitigates proliferation of cervical cancer cells lines. Given the need for novel treatment options for both diseases, our data suggest that tuaimenal A and/or its derivates could culminate in the development of a unique and effective drug.

Keywords

Terpene
Natural Product
Cnidarian
SARS-CoV-2
Vibrational Circular Dichroism
Cancer
Flexible Docking
3CLpro

Supplementary materials

Title
Description
Actions
Title
20220115 ChemRxiv SI tuaimenal A
Description
The following Supporting Information is available: 1H, 13C, 2D NMR, HRESIMS, UV, FTIR spectra, and VCD data for tuaimenal A (1); binding site residues for rigid docking with 3CLpro, Plpro, RdRp, and TMPRSS2 protein targets (PDF).
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.